Pear Therapeutics, Inc.

UEI
LBWUKD3WN139
CAGE
7CP86
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
peartherapeutics.com
Founded
2013
Employees
251-1K
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Pear Therapeutics, Inc.'s 3 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
A prescription digital therapeutic to promote adherence to buprenorphine pharmacotherapy for patients with opioid use… Grant · R44DA049493 National Institute on Drug Abuse $214,833
: developing a virtual environment to enhance patient engagement in peer support in opioid use disorder. September 22,… Contract · HHSN271201700057C National Institute on Drug Abuse $149,514
A game-based intervention for opioid use disorder Grant · R44DA042652 National Institute on Drug Abuse $1,177,278

About Pear Therapeutics, Inc.

Pear Therapeutics, Inc. is a pioneering digital health company focused on developing prescription digital therapeutics to treat diseases with high unmet medical need. It has a pipeline of clinically validated digital therapies and is known for its innovation in the digital therapeutics field.

In 2019, Pear Therapeutics received a $214,833 project grant from the National Institute on Drug Abuse, part of the National Institutes of Health under the Department of Health and Human Services. The grant funded the development of a prescription digital therapeutic to promote adherence to buprenorphine pharmacotherapy for patients with opioid use disorder. The project aimed to create a digital intervention to support and enhance traditional medication-assisted treatment for opioid addiction. The grant underscores Pear Therapeutics' expertise in developing innovative digital solutions for substance abuse and behavioral health issues.

Pear Therapeutics also holds a Federal Supply Schedule contract under the GSA's Medical Equipment and Supplies Schedule (65-II-A). Awarded in 2021, this multiple-award, indefinite-delivery, indefinite-quantity contract has a potential value of $10 million to provide medical equipment and supplies to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. Through this contract, Pear Therapeutics will supply a range of medical equipment and supplies to support healthcare programs serving United States veterans in the mid-Atlantic region. The contract reflects the company's capabilities in delivering medical technologies and solutions to federal healthcare agencies.

Contract vehicles

Quick answers

What is Pear Therapeutics, Inc.'s UEI?

Pear Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is LBWUKD3WN139.

What is Pear Therapeutics, Inc.'s CAGE code?

Pear Therapeutics, Inc.'s CAGE code is 7CP86.

What is Pear Therapeutics, Inc.'s primary NAICS code?

Pear Therapeutics, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Is Pear Therapeutics, Inc. registered in SAM.gov?

Pear Therapeutics, Inc.'s SAM.gov registration expired on July 7, 2023.

Which contract vehicles does Pear Therapeutics, Inc. hold?

Pear Therapeutics, Inc. holds a place on 1 federal contract vehicle: FSS-65-II-A.

What is Pear Therapeutics, Inc.'s most recent federal award?

Pear Therapeutics, Inc.'s most recent federal grant award is A prescription digital therapeutic to promote adherence to buprenorphine pharmacotherapy for patients with opioid use… (R44DA049493), from National Institute on Drug Abuse, on September 30, 2019.

On GovTribe

See Pear Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors